Document is current
Any future updates will be listed below
-
Authors
Xu, Caiming
Mannucci, Alessandro https://orcid.org/0000-0002-1655-6762
Han, Haiyong https://orcid.org/0000-0001-9031-9880
Munoz, Ruben M.
Cridebring, Derek
Darabi, Sourat https://orcid.org/0000-0002-3395-894X
Toiyama, Yuji
Okugawa, Yoshinaga https://orcid.org/0000-0002-0417-5559
Singh, Gagandeep
Raoof, Mustafa
Park, Joon Oh https://orcid.org/0000-0001-6502-2612
Lin, James
Idos, Gregory
Demeure, Michael J.
Borazanci, Erkut https://orcid.org/0000-0001-5136-5462
Evans, Douglas B.
Tsai, Susan
Jun, Eunsung https://orcid.org/0000-0002-5619-2430
Becerra, Carlos
Celinski, Scott A. https://orcid.org/0000-0002-3436-4641
Melstrom, Laleh https://orcid.org/0000-0001-6279-7981
Chung, Vincent
Zhang, Guixin
Shang, Dong
Bartlett, David L.
Kanda, Mitsuro
Kim, Song Cheol https://orcid.org/0000-0003-4552-4169
Anagnastou, Valsamo https://orcid.org/0000-0001-9480-3047
Cavestro, Giulia Martina
Bolton, John S.
Zaidi, Ali H. https://orcid.org/0000-0002-5463-2252
Von Hoff, Daniel https://orcid.org/0000-0003-4723-7681
Goel, Ajay https://orcid.org/0000-0003-1396-6341
-
Funding
Funding for this research was provided by:
Foundation for the National Institutes of Health (CA72851, CA181572, CA184792, CA187956, CA202797, CA214254, and CA271443)
- License Information
-
More Information
Article History
Received: 7 March 2025
Accepted: 5 August 2026
First Online: 16 September 2026
Ethics
Competing interests: H.H. is a scientific advisor for Stromatis Pharma and ImproveBio, and a board member for Atom Therapeutics. V.A. receives research funding to Johns Hopkins University from AstraZeneca and Labcorp/Personal Genome Diagnostics, has received research funding to Johns Hopkins University from Bristol Myers Squibb and Delfi Diagnostics in the past 5 years, and is an advisory board member for AstraZeneca and Neogenomics (compensated) and receives honoraria from Foundation Medicine, Guardant Health, Roche, Thermo Fisher and Labcorp/Personal Genome Diagnostics; these arrangements have been reviewed and approved by the Johns Hopkins University in accordance with its conflict-of-interest policies. V.A. is an inventor on patent applications (63/276,525, 17/779,936, 16/312,152, 16/341,862, 17/047,006 and 17/598,690) submitted by Johns Hopkins University related to cancer genomic analyses, circulating tumor DNA therapeutic response monitoring and immunogenomic features of response to immunotherapy that have been licensed to one or more entities. All other authors declare no competing interests.
